Who is sponsoring NCT03226951?

NCT03226951 is sponsored by Marashi Eye Clinic.

What drugs are being tested in NCT03226951?

Interventions in NCT03226951: Subthreshold 532nm laser.

What condition does NCT03226951 study?

NCT03226951 studies Non Central Diabetic Macular Edema.

Is NCT03226951 still recruiting?

NCT03226951 is currently completed. Last updated 29 October 2018.

Last reviewed 2018-10-29 · How we verify

NCT03226951

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SDM Laser for Non Central Diabetic CSME

Completed NA Last updated 29 October 2018

What this trial tests

NA trial testing Subthreshold 532nm laser in Non Central Diabetic Macular Edema in 8 participants. Completed in 1 February 2018.

Timeline

1 July 2017

Primary endpoint
31 January 2018

1 February 2018

Quick facts

Lead sponsor	Marashi Eye Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	1 July 2017
Primary completion	31 January 2018
Estimated completion	1 February 2018
Sites	1 location across Syria

Drugs / interventions tested

Subthreshold 532nm laser

Conditions studied

Non Central Diabetic Macular Edema — all drugs for Non Central Diabetic Macular Edema →

Sponsor

Marashi Eye Clinic

Who can join

Adults 18 to 90, any sex, with Non Central Diabetic Macular Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Is to determine if SDM laser can reduce macular thickness in non central CSME and stop the progression of non central CSME to central CSME in compare to glycemic control

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Hybrid threshold laser to treat diabetic macular edema: A retrospective analysis single center cohort study.
Marashi A, Zazo A. · · 2022 · cited 1× · PMID 36045820 · DOI 10.1016/j.amsu.2022.104222

Verify or expand the search:

Other Marashi Eye Clinic trials

Trials by the same sponsor.

NCT03606733 — Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03226951 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marashi Eye Clinic
Last refreshed: 29 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03226951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing